1. Home
  2. LEGN vs RHI Comparison

LEGN vs RHI Comparison

Compare LEGN & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • RHI
  • Stock Information
  • Founded
  • LEGN 2014
  • RHI 1948
  • Country
  • LEGN United States
  • RHI United States
  • Employees
  • LEGN N/A
  • RHI N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • RHI Professional Services
  • Sector
  • LEGN Health Care
  • RHI Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • RHI Nasdaq
  • Market Cap
  • LEGN 7.8B
  • RHI 7.9B
  • IPO Year
  • LEGN 2020
  • RHI N/A
  • Fundamental
  • Price
  • LEGN $34.68
  • RHI $74.17
  • Analyst Decision
  • LEGN Strong Buy
  • RHI Hold
  • Analyst Count
  • LEGN 13
  • RHI 6
  • Target Price
  • LEGN $81.54
  • RHI $66.33
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • RHI 801.5K
  • Earning Date
  • LEGN 11-12-2024
  • RHI 01-28-2025
  • Dividend Yield
  • LEGN N/A
  • RHI 2.85%
  • EPS Growth
  • LEGN N/A
  • RHI N/A
  • EPS
  • LEGN N/A
  • RHI 2.75
  • Revenue
  • LEGN $520,183,000.00
  • RHI $5,886,357,000.00
  • Revenue This Year
  • LEGN $120.77
  • RHI N/A
  • Revenue Next Year
  • LEGN $68.54
  • RHI $2.53
  • P/E Ratio
  • LEGN N/A
  • RHI $26.97
  • Revenue Growth
  • LEGN 122.96
  • RHI N/A
  • 52 Week Low
  • LEGN $32.66
  • RHI $57.05
  • 52 Week High
  • LEGN $70.13
  • RHI $88.39
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 32.71
  • RHI 51.46
  • Support Level
  • LEGN $40.97
  • RHI $73.86
  • Resistance Level
  • LEGN $43.96
  • RHI $78.41
  • Average True Range (ATR)
  • LEGN 2.03
  • RHI 1.39
  • MACD
  • LEGN -0.72
  • RHI -0.19
  • Stochastic Oscillator
  • LEGN 16.97
  • RHI 20.15

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates of its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.

Share on Social Networks: